US 10696651
Heterocyclic compound
granted A61KA61K31/437A61K31/4375
Quick answer
US patent 10696651 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/437, A61K31/4375, A61K31/44, A61K31/4406